Health Encyclopedia

Bronchiolitis

Definition

Bronchiolitis is an inflammation of the small passages in the lungs (bronchioles), usually caused by a viral infection.

Causes, incidence, and risk factors

Bronchiolitis usually affects children under the age of 2, with a peak age of 3 to 6 months. It is a common, sometimes severe illness. Respiratory syncytial virus (RSV) is one common cause. Other viruses that can cause bronchiolitis include:

The virus is transmitted from person to person by direct contact with nasal secretions or by airborne droplets. Although RSV generally causes only mild symptoms in an adult, it can cause a severe illness in an infant.

Bronchiolitis is seasonal and appears more often in the fall and winter months. It is a very common reason for infants to be hospitalized during winter and early spring. It is estimated that by the first year, more than half of all infants have been exposed to RSV.

Risk factors include:

Being exposed to cigarette smoke
Being younger than 6 months old
Living in crowded conditions
Never being breastfed
Prematurity (born before 37 weeks gestation)

Symptoms

Some children have infections with few or minor symptoms.

Bronchiolitis begins as a mild upper respiratory infection that, over a period of 2 to 3 days, can develop into increasing respiratory distress with wheezing and a "tight" wheezy cough.

The infant's breathing rate may increase a lot (tachypnea), and the infant may become irritable or anxious-looking. If the disease is severe enough, the infant may turn bluish (cyanotic), which is an emergency.

As the effort of breathing increases, parents may see the child's nostrils flaring with each breath and the muscles between the ribs retracting (intercostal retractions) as the child tries to breathe in air. This can be exhausting for the child, and very young infants may become so tired that they have difficulty maintaining breathing.

Symptoms include:

Bluish skin due to lack of oxygen (cyanosis)
Cough, wheezing, shortness of breath, or difficulty breathing
Fever
Intercostal retractions
Nasal flaring in infants
Rapid breathing (tachypnea)

Signs and tests

Signs include:

Decreased blood oxygen
Wheezing and crackling sounds heard through stethoscope exam of chest

Tests include:

Blood gases
Chest x-ray
Nasal fluid cultures (to determine which virus is present)

Treatment

Sometimes, no treatment is necessary.

Supportive therapy can include:

Chest clapping
Clear fluids
Humidified air
Oxygen
Rest

Antibiotics are not effective against viral infections. Medicines used in the hospital can include albuterol (a medication normally used in asthma) or steroids.

In extremely ill children, antiviral medications (such as ribavirin) are sometimes used. Antiviral treatment may decrease the severity and duration of the illness. To be effective, these medications must be given early in the course of the illness.

Expectations (prognosis)

Usually, the symptoms get better within a week, and breathing difficulty usually improves by the third day. The mortality rate is less than 1%.

Complications

Airways disease, including asthma, later in life
Respiratory failure
Secondary infection, such as pneumonia

Calling your health care provider

Call your health care provider immediately, or go to the emergency room if the child with bronchiolitis:

Becomes lethargic
Develops a bluish color in the skin, nails, or lips
Develops rapid, shallow breathing
Has a cold that suddenly worsens
Has difficulty breathing
Flares nostrils or retracts chest muscles in an effort to breathe

Prevention

Most cases of bronchiolitis are not easily preventable because the viruses that cause the disorder are common in the environment. Careful attention to hand washing, especially around infants, can help prevent the spread of respiratory viruses.

Family members with an upper respiratory infection should be especially careful around infants. Wash your hands often, especially before handling the child.

At this date, there is no RSV vaccine available. However, there is an effective product, called palivizumab (Synagis), for infants who are at high risk of developing severe disease from RSV. Ask your child's doctor whether this medication is right for your child.

Review Date:11/12/2007
Reviewed By:Rachel A. Lewis, M.D., F.A.A.P., Columbia University Pediatric Faculty Practice, New York, NY. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.